Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Common Equity (2016 - 2025)

Elevance Health (ELV) has disclosed Common Equity for 17 consecutive years, with $44.0 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 6.56% to $44.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.0 billion through Dec 2025, up 6.56% year-over-year, with the annual reading at $44.0 billion for FY2025, 6.56% up from the prior year.
  • Common Equity for Q4 2025 was $44.0 billion at Elevance Health, roughly flat from $44.1 billion in the prior quarter.
  • The five-year high for Common Equity was $44.1 billion in Q3 2025, with the low at $33.9 billion in Q1 2021.
  • Average Common Equity over 5 years is $39.1 billion, with a median of $38.4 billion recorded in 2023.
  • The sharpest move saw Common Equity grew 13.86% in 2024, then rose 0.46% in 2025.
  • Over 5 years, Common Equity stood at $36.1 billion in 2021, then grew by 0.53% to $36.3 billion in 2022, then increased by 8.46% to $39.4 billion in 2023, then rose by 4.85% to $41.3 billion in 2024, then rose by 6.56% to $44.0 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $44.0 billion, $44.1 billion, and $43.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.